NeuroMetrix (NASDAQ:NURO) Stock Crosses Above 200 Day Moving Average – Here’s Why

NeuroMetrix, Inc. (NASDAQ:NURO)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.92 and traded as high as $4.40. NeuroMetrix shares last traded at $4.37, with a volume of 11,005 shares changing hands.

Analyst Upgrades and Downgrades

Separately, StockNews.com began coverage on shares of NeuroMetrix in a report on Saturday. They issued a “sell” rating for the company.

NeuroMetrix Stock Performance

The company has a market cap of $8.91 million, a P/E ratio of -0.95 and a beta of 2.18. The firm has a 50 day moving average price of $4.05 and a 200-day moving average price of $3.92.

NeuroMetrix (NASDAQ:NURO) last announced its earnings results on Tuesday, November 5th. The medical device company reported ($0.75) earnings per share (EPS) for the quarter. NeuroMetrix had a negative return on equity of 42.56% and a negative net margin of 203.71%. The company had revenue of $0.59 million for the quarter. During the same period in the prior year, the firm earned ($1.66) earnings per share.

About NeuroMetrix

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.